S.Amdt. 2952Senate111th Congress (2009-2011)2nd degree
S.Amdt. 2952
Sponsored by
Sen. John D. Rockefeller IV (D-WV)
Submitted December 6, 2009
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Floor
Latest Action
Senate amendment submitted
December 6, 2009
Text
Submitted
SA 2952. Mr. Rockefeller submitted an amendment intended to be proposed to amendment SA 2786 proposed by Mr. Reid (for himself, Mr. Baucus, Mr. Dodd, and Mr. Harkin) to the bill H.R. 3590, to amend the Internal Revenue Code of 1986 to modify the first-time homebuyers credit in the case of members of the Armed Forces and certain other Federal employees, and for other purposes; which was ordered to lie on the table; as follows: On page 1925, between lines 14 and 15, insert the following: Subtitle C--Provisions Relating to Authorized Generic Drugs SEC. 7201. PROHIBITION OF AUTHORIZED GENERICS. (a) In General.--Section 505 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355) is amended by adding at the end the following: ``(w) Prohibition of Authorized Generic Drugs.-- ``(1) In general.--Notwithstanding any other provision of this Act, no holder of a new drug application approved under subsection (c) shall manufacture, market, sell, or distribute an authorized generic drug, direct or indirectly, or authorize any other person to manufacture, market, sell, or distribute an authorized generic drug. ``(2) Authorized generic drug.--For purposes of this subsection, the term `authorized generic drug'-- ``(A) means any version of a listed drug (as such term is used in subsection (j)) that the holder of the new drug application approved under subsection (c) for that listed drug seeks to commence marketing, selling, or distributing, directly or indirectly, after receipt of a notice sent pursuant to subsection (j)(2)(B) with respect to that listed drug; and ``(B) does not include any drug to be marketed, sold, or distributed-- ``(i) by an entity eligible for exclusivity with respect to such drug under subsection (j)(5)(B)(iv); or ``(ii) after expiration or forfeiture of any exclusivity with respect to such drug under such subsection (j)(5)(B)(iv).''. (b) Conforming Amendment.--Section 505(t)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 355(t)(3)) is amended by striking ``In this section'' and inserting ``In this subsection''. ____________________